Raymond James analyst Martin Auster downgraded BridgeBio Pharma (BBIO) from Outperform to Market Perform, citing a potential shift in future performance expectations. Despite a GuruFocus (GF) Value of $134.87 suggesting the stock is 50.2% undervalued compared to its current price of $67.13, insider activity shows significant selling, with $25.3 million in shares sold over the last three months. The company's GF Score of 67/100 reveals strong growth potential but weak financial strength and valuation.

Valerie Jabbar, Senior Vice President of Retail Divisions at The Kroger Co., has announced her retirement after 38 years of service. Jabbar began her career as a clerk and steadily ascended through various leadership roles, significantly impacting the company. Her career journey and leadership have been widely recognized within and outside the grocery industry.

The Gross Law Firm has issued a notice to investors of Babcock & Wilcox Enterprises, Inc. (NYSE: BW) regarding a pending class action lawsuit. Shareholders who purchased BW shares between November 5, 2025, and March 11, 2026, are encouraged to contact the firm, as the complaint alleges the company made materially false and/or misleading statements. The lead plaintiff deadline for this class action is June 15, 2026.

American Airlines (AAL) shares surged 5.8% after UBS raised its price target to $18, citing a positive outlook from potential Middle East conflict resolution and maintaining a "Buy" rating. The airline also announced a record summer schedule, expecting to fly 75 million customers. This rise comes amidst a volatile market for AAL, with overall economic factors like easing bond market pressure and lower oil prices also boosting investor sentiment for consumer-facing companies.

Investors are awaiting Zscaler's (ZS) earnings report, with the company commanding a $30 billion market capitalization and a GF Score of 67/100. Despite strong revenue growth of 30.8% over three years, Zscaler faces challenges with negative EPS of -0.42 and insider selling totaling $2.4 million in the last three months. The upcoming report is crucial for investors to assess how Zscaler plans to tackle these issues while capitalizing on the increasing demand for cybersecurity solutions.

Autodesk (ADSK) is set to release its first-quarter fiscal 2027 results on May 28, with market expectations of $1.89 billion in revenues and diluted non-GAAP earnings per share between $2.82 and $2.86. The company is anticipated to have benefited from strong demand in architecture, engineering, and construction, as well as increased adoption of its cloud-based solutions and AI investments, despite potential short-term disruptions from sales and marketing optimization. Zacks analysts predict an earnings beat due to a positive Earnings ESP and a Zacks Rank #3.

Church & Dwight Co., Inc. announced that its President and CEO, Rick Dierker, CFO, Lee McChesney, and EVP International, Michael Read, will participate in the dbAccess Global Consumer Conference on Tuesday, June 2 at 6:00 a.m. EDT. The company, known for brands like ARM & HAMMER® and OXICLEAN®, also recently reported strong Q1 2026 results exceeding expectations and declared its 501st consecutive quarterly dividend. A broadcast link for the conference will be available on the Investors section of Church & Dwight’s website.

RedChip Companies will host an investor webinar featuring Clinch Resources Ltd. (TSX:CLCH) on May 28, 2026, at 4:15 p.m. ET. The event will provide insights into Clinch Resources' strategy to become a low-cost metallurgical coal producer, with plans for initial production in 2026 from its Mine 8 and Lanes Branch operations. Management will discuss the company's cost positioning, resource base, and additional value drivers, followed by a live Q&A session.

Jupiter Neurosciences, Inc. (NASDAQ:JUNS) has closed a registered direct offering of 7,142,858 shares of common stock, generating approximately $2.0 million in gross proceeds. D. Boral Capital LLC acted as the exclusive placement agent for this offering. Jupiter Neurosciences is a clinical-stage biopharmaceutical company focusing on central nervous system disorders and neuroinflammation, with its lead program JOTROL(TM) currently in a Phase IIa clinical trial for Parkinson's disease.

The upcoming Computex Taipei trade show will host keynote speeches from the CEOs of Qualcomm, Intel, Marvell, and NXP Semiconductors, alongside four "heavyweight forums" focusing on robotics, automation, and physical AI, featuring executives from ABB, Nvidia, Qualcomm, and NXP. The event, themed "AI Together," anticipates over 1,500 participating companies and up to 40,000 international buyers, with a strong emphasis on AI and computing, robotics, and next-generation technologies. Its business impact is expected to significantly boost Taiwan's export growth, particularly within AI-related industries.